United States · FDA National Drug Code directory
Everolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70377-090_7f7c486a-aefb-4798-aa9f-365799886a72
- Product NDC
- 70377-090
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- Everolimus
- Labeler
- Biocon Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260114
- Source listing expiry
- 20271231
Source-listed ingredients
- EVEROLIMUS — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-090-11) · 70377-090-11
- 4 BLISTER PACK in 1 CARTON (70377-090-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK · 70377-090-23
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →